Paradigm Biocapital Advisors LP
Position in VRDN — Viridian Therapeutics, Inc.\DE
CIK 1855655
NEW YORK, NY
Position in VRDN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$61,592,347
+$16,683,013 QoQ
Shares Held
3,148,893
+118.2% QoQ
Ownership
3.05%
of shares outstanding
% of Portfolio
1.26%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRDN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Paradigm Biocapital Advisors LP holds $4,894,261,596 across 35 Biotechnology names. VRDN ranks #22 (1.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ACLX |
Arcellx, Inc.
|
5,774,016 | $662,972,517 | |
| 2 | RVMD |
Revolution Medicines, Inc.
|
6,655,703 | $647,267,116 | |
| 3 | NUVL |
Nuvalent, Inc.
|
5,324,433 | $545,488,160 | |
| 4 | PCVX |
Vaxcyte, Inc.
|
4,793,020 | $278,522,392 | |
| 5 | EWTX |
Edgewise Therapeutics, Inc.
|
7,365,038 | $231,998,697 | |
| 6 | GMAB |
Genmab A/S
|
7,967,836 | $213,777,039 | |
| 7 | INSM |
INSMED Inc
|
1,254,488 | $205,133,877 | |
| 8 | TARS |
Tarsus Pharmaceuticals, Inc.
|
2,562,154 | $179,735,103 |
All Filings in VRDN
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-18 | $93,689,894 | 5,633,788 | Shares | Sole | 2026-06-26 | |
| 2026-03-31 | $61,592,347 | 3,148,893 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $44,909,334 | 1,443,102 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $56,309,837 | 2,609,353 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $38,327,232 | 2,741,576 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $28,241,664 | 2,095,079 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $34,890,914 | 1,820,079 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $65,876,924 | 2,895,689 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $37,681,500 | 2,896,349 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $88,100,164 | 5,031,420 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $104,423,948 | 4,794,488 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $56,477,998 | 3,681,747 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $57,458,940 | 2,415,256 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $53,060,157 | 2,085,698 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $51,151,588 | 1,751,167 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $33,558,687 | 1,636,211 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,117,003 | 1,306,569 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $23,224,382 | 1,256,051 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $23,902,938 | 1,209,051 | Shares | Sole | 2022-02-14 | |
| No filing history on record for this holder in this stock. | ||||||